Co-Authors
This is a "connection" page, showing publications co-authored by ALEXANDER KAY and TARA NESS.
Connection Strength
3.546
-
Evaluating antibiotic use and developing a tool to optimize prescribing in a family-centered HIV clinic in Eswatini. PLoS One. 2021; 16(1):e0244247.
Score: 0.688
-
Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis. PLOS Glob Public Health. 2025; 5(11):e0005243.
Score: 0.241
-
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiol Spectr. 2026 Jan 06; 14(1):e0233525.
Score: 0.241
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2025 10 23; 10:CD013359.
Score: 0.240
-
Performance of a Novel Stool Quantitative Polymerase Chain Reaction Assay for Pediatric Tuberculosis Detection in Sub-Saharan Africa. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
Score: 0.234
-
Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens. Int J Tuberc Lung Dis. 2025 Mar 31; 29(4):189-192.
Score: 0.231
-
Rapid Diagnostic Sequencing of Stool DNA Using Targeted Nanopore Sequencing in Patients With a Pulmonary Tuberculosis Diagnosis. Open Forum Infect Dis. 2025 Apr; 12(4):ofaf121.
Score: 0.230
-
Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study. Lancet Microbe. 2024 05; 5(5):e433-e441.
Score: 0.214
-
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.
Score: 0.198
-
Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
Score: 0.196
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 09 06; 9:CD013359.
Score: 0.193
-
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. Am J Trop Med Hyg. 2020 10; 103(4):1348-1349.
Score: 0.169
-
Point-of-Care Testing to Guide Treatment and Estimate Risk Factors for Sexually Transmitted Infections in Adolescents and Young People With Human Immunodeficiency Virus in Eswatini. Open Forum Infect Dis. 2020 Mar; 7(3):ofaa052.
Score: 0.162
-
Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic Culture. Open Forum Infect Dis. 2025 Aug; 12(8):ofaf345.
Score: 0.059
-
Healthcare providers' knowledge, attitudes, and perceptions from using targeted sequencing to diagnose and manage drug-resistant tuberculosis (DR-TB) in Eswatini. PLOS Glob Public Health. 2025; 5(6):e0004718.
Score: 0.058
-
Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2024 Sep; 30(9):1123-1130.
Score: 0.052
-
Correction: Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 Sep 20; 14(1):107.
Score: 0.048
-
Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
Score: 0.047
-
Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev. 2021 06 28; 6:CD013693.
Score: 0.044